ASPE

12.2302.86%

OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • OrbiMed Advisors reported buying 1,000,000 Aspen Neuroscience common shares at $15 each. * Preferred stock conversions added 2,589,132 common shares. * The joint filing with OrbiMed Capital GP VII reported indirect beneficial ownership of 3,589,132 common shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000980), on November 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.